Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
AntibodyDrug Conjugates (ADCs): Target Expansion and Payload Innovation in Parallel In 2025, two new ADCs DATROWAY (datopotamab deruxtecan-dlnk) and Emrelis (telisotuzumab vedotin) received regulatory approval
It produced striking rejuvenation effects in aged mice but no human clinical trials have been conducted
Everything you need is included to get you started and keep you going
Ethics declarations Ethics Statement This research did not involve human participants, animal subjects, or any material that requires ethical approval
US$ 20.77
US$ 21.46
US$ 29.60
US$ 25.73
US$ 22.27
US$ 23.29
